phosphorus has been researched along with osteoprotegerin in 38 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (osteoprotegerin) | Trials (osteoprotegerin) | Recent Studies (post-2010) (osteoprotegerin) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 5,108 | 212 | 2,726 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (44.74) | 29.6817 |
| 2010's | 18 (47.37) | 24.3611 |
| 2020's | 3 (7.89) | 2.80 |
| Authors | Studies |
|---|---|
| Furumoto, H; Ikawa, H; Irahara, M; Kiyokawa, M; Kuwahara, A; Maegawa, M; Matsuzaki, T; Uemura, H; Yasui, T | 1 |
| Akiba, T; Kabaya, T; Kawashima, A; Nihei, H; Nitta, K; Uchida, K; Yumura, W | 1 |
| Hiraoka, BY; Horiuchi, H; Kobayashi, Y; Matsuura, S; Miyazawa, H; Mogi, M; Nakamura, H; Nakamura, M; Ozawa, H; Saito, N; Takahashi, N; Takaoka, K; Udagawa, N | 1 |
| Ichinose, Y; Inoue, M; Mochizuki, S; Seino, Y; Tanaka, H; Tsuda, E | 1 |
| Hirasawa, H; Katae, Y; Mori, T; Nakai, K; Nakamura, T; Sakai, A; Sakuma-Zenke, M; Takeda, T | 1 |
| Ishida, H; Kikuyama, M; Kurose, T; Maruyama, M; Nagamatsu, S; Seino, Y; Sugimoto, C; Suzuki, K; Takizawa, M; Ushikawa, K | 1 |
| Barreto, DV; Barreto, FC; Canziani, ME; Carvalho, AB; Draibe, SA; Jorgetti, V; Moyses, RM; Neves, CL | 1 |
| Roszkowska-Blaim, M; Ziółkowska, H | 1 |
| Cardús, A; Fernandez, E; Panizo, S; Parisi, E; Valdivielso, JM | 1 |
| Cecoli, F; Ceresola, E; De Franchis, V; Fazzuoli, L; Ferone, D; Giusti, M; Minuto, F; Mussap, M | 1 |
| Ballanti, P; Bonucci, E; Gualtieri, N; Leopizzi, M; Monnazzi, P; Patacchioli, FR; Sardella, D; Sebastiani, M; Silvestrini, G; Simeoni, S | 1 |
| Holecki, M; Janowska, J; Nieszporek, T; Wiecek, A; Wojaczyńska-Stanek, K; Zahorska-Markiewicz, B; Zak-Gołab, A | 1 |
| Anastasilakis, AD; Avramidis, A; Gerou, S; Goulis, DG; Koukoulis, G; Pavlidou, V; Polyzos, SA | 1 |
| Arisawa, K; Hiyoshi, M; Irahara, M; Miyatani, Y; Uemura, H; Yamada, M; Yasui, T | 1 |
| Gu, JH; Liu, JD; Liu, ZP; Shen, Y | 1 |
| dos Reis, LM; Graciolli, FG; Graciolli, RG; Jorgetti, V; Moysés, RM; Neves, KR; Noronha, IL | 1 |
| Han, T; Li, N; Qin, LP; Wu, YB; Zhang, H; Zhang, QY | 1 |
| Hosoya, T; Kagami, S; Ohkido, I; Yokoyama, K | 1 |
| Li, Q; Li, X; Wan, HY; Wong, MS; Zhang, Y | 1 |
| Hofbauer, LC; Kavurma, MM; Schoppet, M; Shanahan, CM | 1 |
| Ortega, E; Osorio, A; Ruiz-Requena, E; Sanchez, P; Torres, JM | 1 |
| Kurabayashi, M | 1 |
| Bogdan, C; Dall'Ara, E; Dwyer, D; Kostenuik, P; Mayrhofer, E; Pendl, G; Pietschmann, P; Rauner, M; Resch, H; Sipos, W; Sommerfeld-Stur, I; Stolina, M; Varga, P; Zysset, P | 1 |
| Cai, Y; Du, J; Duan, XH; Qi, YF; Song, JQ; Tang, CS; Teng, X; Zhang, J; Zhou, YB | 1 |
| Kong, XH; Li, C; Li, Q; Li, YH; Liu, L; Mei, QB; Niu, YB; Sun, Y; Wang, J; Zhang, R | 1 |
| Goltzman, D; Miao, D; Sun, W; Yan, J; Zhang, J | 1 |
| Argani, H; Ghorbanihaghjo, A; Mahmoudi Meimand, S; Rashtchizadeh, N; Safa, J; Shahidi, M; Vatankhahan, H | 1 |
| Atkinson, EJ; Gössl, M; Kane, TL; Khosla, S; Lerman, A; McCready, LK; McGregor, UI; Peris, P | 1 |
| Almeida, MG; Arrais, RF; Brandão-Neto, J; Duarte, VM; Freire-Neto, FP; Hirata, MH; Hirata, RD; Loureiro, MB; Luchessi, AD; Maciel-Neto, JJ; Oliveira, GH; Rezende, AA; Ururahy, MA | 1 |
| Chen, B; Chen, J; Huang, H; Li, H; Pang, G; Xie, J | 1 |
| Bideci, A; Bukan, N; Camurdan, OM; Çelik, N; Cinaz, P; Döğer, E; Emeksiz, HC; Gayretli Aydin, ZG; Yildiz, U | 1 |
| Abreu, BJ; Almeida, MG; Bezerra, JF; Bortolin, RH; Brandão-Neto, J; Didone, TVN; Doi, SQ; Ferreira, ECS; Freire-Neto, FP; Himelfarb, ST; Hirata, MH; Hirata, RDC; Medeiros, AC; Pedrosa, LFC; Ramos, AMO; Rezende, AA; Rezende, LA; Souza, KSC; Ururahy, MAG | 1 |
| Cunha, FQ; de Paula, FJA; Dick-de-Paula, I; Fukada, SY; Jordão, AA; Jorgetti, V; Nogueira-Barbosa, MH; Ramalho, LNZ; Spirlandeli, AL; Volpon, JB; Zamarioli, A | 1 |
| Abd El Wahab, AM; El-Azab, GA; Elshahawy, H; Mostafa, TM; Sayed-Ahmed, NA; Zakaria, H | 1 |
| Brasilino, MDS; Chaves-Neto, AH; Crivelini, MM; de Melo Stevanato Nakamune, AC; Dornelles, RCM; Ervolino, E; Leopoldino, AM; Pereira, AAF; Pereira, CS; Stringhetta, K; Stringhetta-Garcia, CT | 1 |
| Jang, HJ; Kwon, GJ; Lee, EC; Seo, YK | 1 |
| Belova, SV; Ulyanov, VY; Zubavlenko, RА | 1 |
| Ainetdinova, AR; Dmitriev, IV; Eremkina, AK; Gavrilova, AO; Larina, II; Maganeva, IS; Pinchuk, AV; Severina, AS; Shamhalova, MS; Shestakova, MV | 1 |
1 review(s) available for phosphorus and osteoprotegerin
| Article | Year |
|---|---|
[Bone and calcium update; diagnosis and therapy of bone metabolism disease update. Calcification of atherosclerotic plaques: mechanism and clinical significance].
Topics: Animals; Bone Morphogenetic Protein 2; Calcium; Core Binding Factor Alpha 1 Subunit; Coronary Disease; Coronary Vessels; Humans; Mice; Osteoprotegerin; Phosphorus; Plaque, Atherosclerotic; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Notch; Risk; Vascular Calcification | 2011 |
2 trial(s) available for phosphorus and osteoprotegerin
| Article | Year |
|---|---|
Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women.
Topics: Biomarkers; Bone Density; Bone Density Conservation Agents; C-Reactive Protein; Calcium; Creatinine; Double-Blind Method; Down-Regulation; Endothelium; Enzyme-Linked Immunosorbent Assay; Etidronic Acid; Female; Flow Cytometry; Gene Expression Regulation; Humans; Interleukin-8; Middle Aged; Osteoblasts; Osteogenesis; Osteoporosis, Postmenopausal; Osteoprotegerin; Phosphorus; Placebos; RANK Ligand; Risedronic Acid; Stem Cells; Treatment Outcome; Vitamin D | 2013 |
The impact of fish oil and wheat germ oil combination on mineral-bone and inflammatory markers in maintenance hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Alkaline Phosphatase; Antioxidants; Biomarkers; C-Reactive Protein; Calcium; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Ferritins; Fish Oils; Hemoglobins; Humans; Kidney Failure, Chronic; Leukocyte Count; Male; Middle Aged; Osteoprotegerin; Parathyroid Hormone; Phosphorus; Plant Oils; Prospective Studies; Renal Dialysis; Uric Acid | 2017 |
35 other study(ies) available for phosphorus and osteoprotegerin
| Article | Year |
|---|---|
Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Bone Resorption; Calcium; Case-Control Studies; Collagen; Collagen Type I; Enzyme-Linked Immunosorbent Assay; Female; Glycoproteins; Humans; Lactation; Osteoprotegerin; Parathyroid Hormone; Peptides; Phosphorus; Pregnancy; Pregnancy Trimesters; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Regression Analysis; Serum Albumin; Statistics, Nonparametric; Vitamin D | 2002 |
The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.
Topics: Aortic Diseases; Arteriosclerosis; C-Reactive Protein; Calcinosis; Calcium; Calcium Carbonate; Disease Progression; Female; Glycoproteins; Humans; Kidney Failure, Chronic; Lipids; Longitudinal Studies; Male; Middle Aged; Osteoprotegerin; Parathyroid Hormone; Phosphorus; Prospective Studies; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Renal Dialysis; Risk Factors | 2003 |
Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Resorption; Calcium; Calcium Channel Blockers; Carrier Proteins; Etidronic Acid; Glycoproteins; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Osteocalcin; Osteogenesis; Osteoprotegerin; Phosphorus; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Risedronic Acid; Transforming Growth Factor beta | 2003 |
Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading.
Topics: Amino Acids; Animals; Bone Density; Bone Diseases, Metabolic; Calcium; Elasticity; Femur; Glycoproteins; Hindlimb Suspension; Male; Osteoclasts; Osteoprotegerin; Phosphorus; Radiography; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Stress, Mechanical; Tibia; Weight-Bearing | 2004 |
Osteoclast development in immobilized bone is suppressed by parathyroidectomy in mice.
Topics: Animals; Bone and Bones; Bone Marrow Cells; Calcium; Carrier Proteins; Cell Differentiation; Cells, Cultured; Cytokines; Glycoproteins; Hindlimb Suspension; Male; Membrane Glycoproteins; Mice; Organ Size; Osteoclasts; Osteoprotegerin; Parathyroidectomy; Phosphorus; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; RNA, Messenger | 2005 |
Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.
Topics: Acid Phosphatase; Amino Acids; Biomarkers; Bone Density; C-Peptide; Calcitriol; Calcium; Collagen; Collagen Type I; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Glycoproteins; Humans; Insulin; Isoenzymes; Magnesium; Male; Middle Aged; Osteocalcin; Osteoclasts; Osteoprotegerin; Parathyroid Hormone; Peptides; Phosphorus; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Sex Factors; Tartrate-Resistant Acid Phosphatase | 2005 |
Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Biopsy; Bone and Bones; Bone Diseases, Metabolic; Bone Remodeling; Calcium; Carrier Proteins; Case-Control Studies; Cross-Sectional Studies; Female; Glycoproteins; Humans; Male; Membrane Glycoproteins; Middle Aged; Osteoporosis; Osteoprotegerin; Parathyroid Hormone; Phosphorus; Prevalence; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Renal Dialysis; Vitamin D; White People | 2006 |
[Osteoprotegerin and calcium-phosphorus metabolism parameters in children with chronic renal failure].
Topics: Adolescent; Adult; Calcium; Child; Child, Preschool; Humans; Kidney Failure, Chronic; Osteocalcin; Osteoprotegerin; Phosphorus | 2006 |
Differential effects of vitamin D analogs on vascular calcification.
Topics: Animals; Aorta; Blood Pressure; Bone Density Conservation Agents; Calcinosis; Calcitriol; Calcium; Cells, Cultured; Ergocalciferols; Gene Expression; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nephrectomy; Osteoprotegerin; Parathyroid Hormone; Phosphorus; RANK Ligand; Rats; Rats, Sprague-Dawley; Vascular Diseases; Vitamin D | 2007 |
Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Calcium; Case-Control Studies; Cohort Studies; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Osteoprotegerin; Parathyroid Hormone; Phosphorus; RANK Ligand; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin; Thyroxine | 2007 |
Effects of the administration of corticosterone, parathyroid hormone, or both, and of their withdrawal, on rat bone and cartilage histomorphometric parameters, and on osteoprotegerin and RANKL mRNA expression and proteins.
Topics: Animals; Anti-Inflammatory Agents; Bone and Bones; Calcium; Cartilage; Corticosterone; Immunohistochemistry; In Situ Hybridization; Male; Osteoprotegerin; Parathyroid Hormone; Phosphorus; RANK Ligand; Rats; Rats, Wistar; RNA, Messenger | 2007 |
The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women.
Topics: Body Mass Index; Bone Density; Calcifediol; Calcium; Collagen Type I; Female; Humans; Middle Aged; Obesity; Osteocalcin; Osteoprotegerin; Parathyroid Hormone; Peptides; Phosphorus; Weight Loss; X-Rays | 2007 |
Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappaB ligand levels in women with established osteoporosis treated with teriparatide.
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Density Conservation Agents; Calcium; Female; Humans; Osteoporosis, Postmenopausal; Osteoprotegerin; Phosphorus; Prospective Studies; RANK Ligand; Teriparatide | 2008 |
Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand in post-menopausal women.
Topics: Alkaline Phosphatase; Bone Density; Calcium; Collagen Type I; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Osteoprotegerin; Parathyroid Hormone; Peptides; Phosphorus; Postmenopause; RANK Ligand; Solubility | 2008 |
Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro.
Topics: Animals; Calcium; Cells, Cultured; Ducks; Osteoclasts; Osteoprotegerin; Phosphorus; RANK Ligand | 2009 |
Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia.
Topics: Animals; Aorta, Thoracic; Calcinosis; Collagen Type I; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Male; Muscle, Smooth, Vascular; Nephrectomy; Osteoprotegerin; Parathyroid Hormone; Parathyroidectomy; Phenotype; Phosphorus; Phosphorus, Dietary; Rats; Rats, Wistar; Risk Factors; Uremia | 2009 |
Inhibitory effects of morinda officinalis extract on bone loss in ovariectomized rats.
Topics: Acid Phosphatase; Adrenocorticotropic Hormone; Animals; Body Weight; Bone Density; Calcium; Chromatography, High Pressure Liquid; Corticosterone; Female; Interleukin-6; Isoenzymes; Molecular Structure; Morinda; Organ Size; Osteoprotegerin; Ovariectomy; Phosphorus; Plant Extracts; Rats; Rats, Sprague-Dawley; Tartrate-Resistant Acid Phosphatase; Tumor Necrosis Factor-alpha | 2009 |
The hypothesis that bone turnover influences FGF23 secretion.
Topics: Animals; Bone and Bones; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Mice; Mice, Knockout; Models, Biological; Osteoprotegerin; Phosphorus; Randomized Controlled Trials as Topic; RNA, Messenger | 2010 |
Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption.
Topics: Acid Phosphatase; Animals; Bone Density Conservation Agents; Bone Resorption; Calcium; Cathepsin K; Cell Differentiation; Erythrina; Female; Genistein; Isoenzymes; Macrophages; Mice; Osteoclasts; Osteoporosis; Osteoprotegerin; Ovariectomy; Phosphorus; Phytotherapy; Plant Extracts; RANK Ligand; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tartrate-Resistant Acid Phosphatase | 2010 |
Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin.
Topics: Calcification, Physiologic; Calcinosis; Calcium; Crystallization; Humans; Microscopy, Confocal; Muscle, Smooth; Muscle, Smooth, Vascular; Nanoparticles; Osteoprotegerin; Phosphorus; Plaque, Atherosclerotic | 2011 |
Mineral-bone metabolism markers in young hemodialysis patients.
Topics: Acid Phosphatase; Adolescent; Adult; Alkaline Phosphatase; Atherosclerosis; Biomarkers; Bone and Bones; Bone Density; Calcifediol; Calcitriol; Calcium; Case-Control Studies; Humans; Isoenzymes; Kidney Failure, Chronic; Osteocalcin; Osteoprotegerin; Parathyroid Hormone; Phosphorus; Prognosis; RANK Ligand; Renal Dialysis; Tartrate-Resistant Acid Phosphatase; Young Adult | 2011 |
OPG-Fc treatment in growing pigs leads to rapid reductions in bone resorption markers, serum calcium, and bone formation markers.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Biomarkers; Bone and Bones; Bone Resorption; Calcium; Female; Humans; Immunoglobulin Fc Fragments; Male; Osteoprotegerin; Phosphorus; RANK Ligand; Swine | 2011 |
Insulin resistance induces medial artery calcification in fructose-fed rats.
Topics: Alkaline Phosphatase; Animals; Aorta, Thoracic; Blood Glucose; Bone Morphogenetic Proteins; Calcium; Calcium-Binding Proteins; Cell Differentiation; Core Binding Factor Alpha 1 Subunit; Dietary Carbohydrates; Extracellular Matrix Proteins; Fructose; Glucose Tolerance Test; Insulin; Insulin Resistance; Lipid Peroxidation; Male; Matrix Gla Protein; Muscle, Smooth, Vascular; Osteopontin; Osteoprotegerin; Phosphorus; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium-Phosphate Cotransporter Proteins, Type III; Tunica Media; Vascular Calcification | 2012 |
The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action.
Topics: Animals; Body Weight; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Calcium; Cell Differentiation; Cell Proliferation; Cells, Cultured; Dipsacaceae; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Estradiol; Female; Femur; Organ Size; Osteoblasts; Osteoclasts; Osteoporosis; Osteoprotegerin; Ovariectomy; Phosphorus; RANK Ligand; Rats; Rats, Sprague-Dawley; Saponins; Tomography, X-Ray Computed; Up-Regulation; Uterus | 2012 |
Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Ablation Techniques; Animals; Bone Marrow; Bone Remodeling; Bone Resorption; Calcium; Femur; Mice; Mice, Knockout; Osteoclasts; Osteogenesis; Osteoprotegerin; Parathyroid Hormone; Phosphorus; RANK Ligand; X-Ray Microtomography | 2012 |
Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients.
Topics: Adult; Age Factors; Calcinosis; Calcium; Female; Humans; Kidney Transplantation; Male; Middle Aged; Osteoprotegerin; Parathyroid Hormone; Phosphorus; RANK Ligand; Renal Dialysis; Renal Insufficiency; Time Factors | 2012 |
Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes.
Topics: Adolescent; Adult; Alkaline Phosphatase; Biomarkers; Bone Density; Calcium; Case-Control Studies; Child; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Female; Humans; Hyperglycemia; Hypoglycemia; Leukocytes, Mononuclear; Male; Osteocalcin; Osteoprotegerin; Phosphorus; RANK Ligand; Real-Time Polymerase Chain Reaction; Receptor Activator of Nuclear Factor-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Young Adult | 2014 |
Anti-osteoporotic activity of puerarin 6"-O-xyloside on ovariectomized mice and its potential mechanism.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Calcium; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glycosides; Humans; Isoflavones; Mice, Inbred ICR; Osteoblasts; Osteoporosis, Postmenopausal; Osteoprotegerin; Ovariectomy; Phosphorus; RANK Ligand; Time Factors | 2016 |
Assessment of bone turnover markers and bone mineral density in normal short boys.
Topics: Alkaline Phosphatase; Biomarkers; Body Height; Bone Density; Bone Remodeling; Calcium; Child; Humans; Lumbar Vertebrae; Male; Osteocalcin; Osteoprotegerin; Parathyroid Hormone; Phosphorus; Puberty, Delayed; Radiography; Vitamin D | 2015 |
Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats.
Topics: Alkaline Phosphatase; Animals; Blood Glucose; Bone and Bones; Bone Density; Calcium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dietary Supplements; Female; Osteoprotegerin; Ovariectomy; Phosphorus; RANK Ligand; Rats; Rats, Wistar; Zinc | 2017 |
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Carbon Tetrachloride; Core Binding Factor Alpha 1 Subunit; Diphosphonates; Disease Models, Animal; Liver Cirrhosis; Liver Diseases; Male; Mice, Inbred C57BL; Osteoprotegerin; Pamidronate; Phosphorus; RANK Ligand; Tartrate-Resistant Acid Phosphatase; X-Ray Microtomography | 2017 |
Mate tea (Ilex paraguariensis) improves bone formation in the alveolar socket healing after tooth extraction in rats.
Topics: Alkaline Phosphatase; Animals; Antioxidants; Beverages; Calcium; Ilex paraguariensis; Immunohistochemistry; Male; Malondialdehyde; Osteocalcin; Osteogenesis; Osteoprotegerin; Phosphorus; RANK Ligand; Rats; Rats, Wistar; Superoxide Dismutase; Tartrate-Resistant Acid Phosphatase; Tooth Extraction; Tooth Socket | 2018 |
The effect of coated nano-hydroxyapatite concentration on scaffolds for osteogenesis.
Topics: Animals; Bone Morphogenetic Protein 2; Calcium; Cell Differentiation; Cell Proliferation; Coated Materials, Biocompatible; Collagen Type III; Dental Pulp; Durapatite; Fibronectins; Gene Expression Regulation; Humans; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Osteogenesis; Osteoprotegerin; Oxygen; Phosphorus; RNA, Messenger; Silk; Surface Properties; Tissue Engineering; Tissue Scaffolds | 2020 |
Metabolism of Subchondral Bone Tissue in Posttraumatic Osteoarthrosis in Rats.
Topics: Animals; Animals, Outbred Strains; Bone and Bones; Calcium; Cartilage, Articular; Disease Models, Animal; Knee Injuries; Knee Joint; Male; Osteoarthritis, Knee; Osteocalcin; Osteoprotegerin; Phosphorus; Rats | 2021 |
[Advanced glycation end products and oxidative stress as a basis for metabolic abnormalities in patients with type 1 diabetes after successful simultaneous pancreas-kidney transplantation].
Topics: alpha-2-HS-Glycoprotein; C-Peptide; Calcium; Diabetes Mellitus, Type 1; Glycated Hemoglobin; Glycation End Products, Advanced; Graft Survival; Humans; Kidney Transplantation; Minerals; Osteoprotegerin; Oxidative Stress; Pancreas; Pancreas Transplantation; Parathyroid Hormone; Phosphorus; Vitamin D | 2021 |